Search

Your search keyword '"Stone, William S."' showing total 84 results

Search Constraints

Start Over You searched for: Author "Stone, William S." Remove constraint Author: "Stone, William S." Publisher elsevier bv Remove constraint Publisher: elsevier bv
84 results on '"Stone, William S."'

Search Results

1. PsyCog: A computerised mini battery for assessing cognition in psychosis

2. 451. Group Iterative Multiple Model Estimation Reveals Individuals at Clinical High-Risk for Psychosis and Healthy Comparisons Self-Organize by Premorbid Adjustment According to Patterns of Temporoparietal Brain Connectivity

3. Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studies

4. Use of the Chinese version of the MATRICS Consensus Cognitive Battery to assess cognitive functioning in individuals with high risk for psychosis, first-episode schizophrenia and chronic schizophrenia: a systematic review and meta-analysis

5. Relations of Lifetime Perceived Stress and Basal Cortisol With Hippocampal Volume Among Healthy Adolescents and Those at Clinical High Risk for Psychosis: A Structural Equation Modeling Approach

6. 551. Cerebellar Circuit Manipulation Ameliorates Hallucinations, Negative Symptoms, and Cognitive Deficits in Psychosis

7. 408. Associations Between Area-Level Social Fragmentation During Childhood, Discrimination, and Lower Positive Core Schemas in Healthy Controls and Clinical High Risk for Psychosis Participants

8. Ethnoracial discrimination and the development of suspiciousness symptoms in individuals at clinical high-risk for psychosis

11. Cannabis use and attenuated positive and negative symptoms in youth at clinical high risk for psychosis

12. Family history of psychosis in youth at clinical high risk: A replication study

15. The associations between area-level residential instability and gray matter volumes from the North American Prodrome Longitudinal Study (NAPLS) consortium

16. Association between residential instability at individual and area levels and future psychosis in adolescents at clinical high risk from the North American Prodrome Longitudinal Study (NAPLS) consortium

18. MK-Curve improves sensitivity to identify white matter alterations in clinical high risk for psychosis

19. Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis

20. Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit

21. Depression: An actionable outcome for those at clinical high-risk

22. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes

24. P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature

25. Heritability of acoustic startle magnitude and latency from the consortium on the genetics of schizophrenia

26. Advancing study of cognitive impairments for antipsychotic-naïve psychosis comparing high-income versus low- and middle-income countries with a focus on urban China: Systematic review of cognition and study methodology

27. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort

28. Brain functional connectivity data enhance prediction of clinical outcome in youth at risk for psychosis

30. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services

31. Deficient prepulse inhibition in schizophrenia in a multi-site cohort: Internal replication and extension

33. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study

34. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers

35. Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study

36. The utility of P300 as a schizophrenia endophenotype and predictive biomarker: Clinical and socio-demographic modulators in COGS-2

37. Neurocognitive performance in family-based and case-control studies of schizophrenia

38. Attention/vigilance in schizophrenia: Performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS)

39. Factor structure and heritability of endophenotypes in schizophrenia: Findings from the Consortium on the Genetics of Schizophrenia (COGS-1)

40. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies

41. California Verbal Learning Test-II performance in schizophrenia as a function of ascertainment strategy: Comparing the first and second phases of the Consortium on the Genetics of Schizophrenia (COGS)

42. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: Characterization of demographic, clinical, cognitive, and functional correlates in COGS-2

43. Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) Study: The moderating role of smoking status and antipsychotic medications

44. Paternal age of schizophrenia probands and endophenotypic differences from unaffected siblings

47. Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS

48. Spatial and Temporal Mapping of De Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network

49. Sex Differences in Familiality Effects on Neurocognitive Performance in Schizophrenia

Catalog

Books, media, physical & digital resources